• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生态群特征与益生菌补充剂对普瑞德-威利综合征成人排便的疗效:一项随机、双盲、交叉试验。

Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial.

机构信息

Department of Food Science and Human Nutrition, University of Florida, Gainesville, FL, USA.

Division of Endocrinology, Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USA.

出版信息

Mol Genet Genomic Med. 2020 Dec;8(12):e1535. doi: 10.1002/mgg3.1535. Epub 2020 Oct 25.

DOI:10.1002/mgg3.1535
PMID:33103385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7767560/
Abstract

BACKGROUND

Probiotics may provide a benefit for adults with Prader-Willi syndrome (PWS) experiencing constipation. The primary aim was to determine if Bifidobacterium animalis ssp. lactis B94 (B. lactis B94) improves stool frequency, with secondary aims of stool form and gastrointestinal symptoms. Exploratory aims included diet quality and fecal microbiota composition.

METHODS

Following a 4-week baseline, 25 adults with PWS were randomized to consume B. lactis B94 by capsule (15 billion) or placebo for 4 weeks, followed by 4-week washout in a double-blind, crossover design. Stool frequency and Bristol Stool Form (BSF) were assessed daily, and Gastrointestinal Symptom Rating Scale (GSRS) and dietary intake (7-days food records), per period. Fecal microbiota per period was analyzed using 16S rRNA gene amplicon sequencing and taxa of interest by qPCR (n = 24).

RESULTS

No adverse events were reported. Stool frequency at baseline (n = 25; 2.0 ± 0.1 stools/day), GSRS syndromes, and microbiota composition did not differ with the probiotic intervention overall; however, a delayed, carry-over effect on BSF types 6 and 7 was seen. Diet quality by HEI-2015 was 65.4 ± 8.5.

CONCLUSION

In adults with PWS, B. lactis B94 exhibited little effect on laxation over 4 weeks; however, further research is needed.

摘要

背景

益生菌可能对患有普拉德-威利综合征(PWS)并伴有便秘的成年人有益。主要目的是确定双歧杆菌乳亚种 B94(B. lactis B94)是否能提高粪便频率,次要目的是评估粪便形态和胃肠道症状。探索性目的包括饮食质量和粪便微生物群落组成。

方法

在 4 周基线期后,25 名 PWS 成年人随机分为益生菌组(服用 B. lactis B94 胶囊,剂量为 150 亿)或安慰剂组,各持续 4 周,然后进行双盲交叉洗脱期 4 周。每天评估粪便频率和布里斯托粪便形态(Bristol Stool Form,BSF),每个时期评估胃肠道症状评分量表(Gastrointestinal Symptom Rating Scale,GSRS)和饮食摄入量(7 天食物记录)。每个时期的粪便微生物群落均采用 16S rRNA 基因扩增子测序进行分析,并通过 qPCR 分析感兴趣的分类群(n=24)。

结果

未报告不良事件。基线期(n=25;2.0±0.1 次/天)的粪便频率、GSRS 综合征和微生物群落组成在整个益生菌干预过程中均无差异;然而,BSF 类型 6 和 7 出现了延迟的、持续的效应。根据 HEI-2015 的饮食质量评分为 65.4±8.5。

结论

在 PWS 成年人中,B. lactis B94 在 4 周内对排便的影响很小;然而,需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/7767560/096369bc3785/MGG3-8-e1535-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/7767560/f8e898c8b377/MGG3-8-e1535-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/7767560/a6b67b617631/MGG3-8-e1535-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/7767560/1ee5765a604c/MGG3-8-e1535-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/7767560/4c93b1674b0c/MGG3-8-e1535-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/7767560/096369bc3785/MGG3-8-e1535-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/7767560/f8e898c8b377/MGG3-8-e1535-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/7767560/a6b67b617631/MGG3-8-e1535-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/7767560/1ee5765a604c/MGG3-8-e1535-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/7767560/4c93b1674b0c/MGG3-8-e1535-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/7767560/096369bc3785/MGG3-8-e1535-g005.jpg

相似文献

1
Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial.微生态群特征与益生菌补充剂对普瑞德-威利综合征成人排便的疗效:一项随机、双盲、交叉试验。
Mol Genet Genomic Med. 2020 Dec;8(12):e1535. doi: 10.1002/mgg3.1535. Epub 2020 Oct 25.
2
The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial.动物双歧杆菌乳亚种B94对普拉德-威利综合征成人胃肠道健康的影响:一项随机对照试验的研究方案
Trials. 2018 Apr 27;19(1):256. doi: 10.1186/s13063-018-2648-x.
3
Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial.膳食纤维或益生菌对功能性便秘症状的影响及肠道微生物群的作用:一项双盲随机安慰剂试验。
Gut Microbes. 2023 Jan-Dec;15(1):2197837. doi: 10.1080/19490976.2023.2197837.
4
Altered Salivary Microbiota Following Bifidobacterium animalis Subsp. Lactis BL-11 Supplementation Are Associated with Anthropometric Growth and Social Behavior Severity in Individuals with Prader-Willi Syndrome.双歧杆菌动物亚种。乳杆菌 BL-11 补充后唾液微生物群的改变与 Prader-Willi 综合征个体的人体测量生长和社会行为严重程度相关。
Probiotics Antimicrob Proteins. 2022 Aug;14(4):699-711. doi: 10.1007/s12602-022-09938-0. Epub 2022 Apr 26.
5
Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: A randomized controlled trial.益生菌产品对功能性便秘患者肠道习惯和微生物特征的影响:一项随机对照试验。
J Dig Dis. 2019 Sep;20(9):435-446. doi: 10.1111/1751-2980.12797. Epub 2019 Aug 1.
6
Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.益生菌可改善慢性便秘患者的粪便稠度:一项随机、双盲、安慰剂对照研究。
Dig Dis Sci. 2018 Oct;63(10):2754-2764. doi: 10.1007/s10620-018-5139-8. Epub 2018 Jun 7.
7
Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.双歧杆菌动物亚种 HN019 补充剂对功能性便秘成人结肠传输时间和胃肠道症状的影响:一项双盲、随机、安慰剂对照、剂量范围研究。
Gut Microbes. 2018;9(3):236-251. doi: 10.1080/19490976.2017.1412908. Epub 2018 Feb 8.
8
Bifidobacterium animalis subsp. lactis BLa80 regulates the intestinal habit in adults with chronic constipation: a multicentre, randomised, double-blind, placebo-controlled study.动物双歧杆菌亚种乳双歧杆菌 BLa80 调节慢性便秘成年人的肠道习惯:一项多中心、随机、双盲、安慰剂对照研究。
Benef Microbes. 2024 Sep 5;15(6):679-688. doi: 10.1163/18762891-bja00038.
9
Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation.随机临床试验:双歧杆菌 NCC2818 益生菌与安慰剂对照,以及对慢性便秘患者肠道传输时间、症状和肠道微生物群的影响。
Aliment Pharmacol Ther. 2019 Feb;49(3):251-264. doi: 10.1111/apt.15073. Epub 2018 Dec 25.
10
Effects of Subsp. (BPL1) Supplementation in Children and Adolescents with Prader-Willi Syndrome: A Randomized Crossover Trial.BPL1 补充对 Prader-Willi 综合征儿童和青少年的影响:一项随机交叉试验。
Nutrients. 2020 Oct 13;12(10):3123. doi: 10.3390/nu12103123.

引用本文的文献

1
Rheological Properties and Sensory Profile of Yoghurt Produced with Novel Combination of Probiotic Cultures.新型益生菌组合发酵酸奶的流变学特性与感官特性
Foods. 2024 Sep 24;13(19):3021. doi: 10.3390/foods13193021.
2
Assessing Gastrointestinal Tolerance in Healthy Adults: Reliability and Validity of a Weekly Questionnaire.评估健康成年人的胃肠道耐受性:每周问卷的信度和效度
Curr Dev Nutr. 2023 Jul 20;7(8):101976. doi: 10.1016/j.cdnut.2023.101976. eCollection 2023 Aug.
3
Identification of food and nutrient components as predictors of colonization.

本文引用的文献

1
The Gut Microbiota Profile in Children with Prader-Willi Syndrome.普拉德-威利综合征儿童的肠道微生物群特征。
Genes (Basel). 2020 Aug 7;11(8):904. doi: 10.3390/genes11080904.
2
The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials.益生菌治疗便秘型肠易激综合征患者的疗效和安全性:基于十七项随机对照试验的系统评价和荟萃分析。
Int J Surg. 2020 Jul;79:111-119. doi: 10.1016/j.ijsu.2020.04.063. Epub 2020 May 6.
3
Safety and Effect of a Low- and High-Dose Multi-Strain Probiotic Supplement on Microbiota in a General Adult Population: A Randomized, Double-Blind, Placebo-Controlled Study.
确定食物和营养成分作为定植预测指标。
Front Nutr. 2023 Apr 21;10:1118679. doi: 10.3389/fnut.2023.1118679. eCollection 2023.
4
Unique Features of the Gut Microbiome Characterized in Animal Models of Angelman Syndrome.肠道微生物组在天使综合征动物模型中的独特特征。
mSystems. 2023 Feb 23;8(1):e0060822. doi: 10.1128/msystems.00608-22. Epub 2023 Jan 4.
5
Intake of MPRO3 over 4 Weeks Reduces Glucose Levels and Improves Gastrointestinal Health and Metabolism.连续4周摄入MPRO3可降低血糖水平,并改善胃肠道健康和新陈代谢。
Microorganisms. 2021 Dec 31;10(1):88. doi: 10.3390/microorganisms10010088.
6
Targeting the Gut Microbiome in Prader-Willi Syndrome.针对普拉德-威利综合征的肠道微生物群
J Clin Med. 2021 Nov 16;10(22):5328. doi: 10.3390/jcm10225328.
7
The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.雷特氏乳杆菌 LR-99 补充剂对普拉德-威利综合征患者体重指数、社会交流、精细运动功能和肠道微生物组成的影响:一项随机、双盲、安慰剂对照试验。
Probiotics Antimicrob Proteins. 2021 Dec;13(6):1508-1520. doi: 10.1007/s12602-021-09800-9. Epub 2021 Jun 11.
8
Adults with Prader-Willi syndrome exhibit a unique microbiota profile.患有普拉德-威利综合征的成年人表现出独特的微生物群特征。
BMC Res Notes. 2021 Feb 6;14(1):51. doi: 10.1186/s13104-021-05470-6.
低、高剂量多菌株益生菌补充剂对一般成年人群肠道菌群的安全性和有效性:一项随机、双盲、安慰剂对照研究。
J Diet Suppl. 2021;18(3):227-247. doi: 10.1080/19390211.2020.1749751. Epub 2020 Apr 20.
4
Microbiota Stability and Gastrointestinal Tolerance in Response to a High-Protein Diet with and without a Prebiotic, Probiotic, and Synbiotic: A Randomized, Double-Blind, Placebo-Controlled Trial in Older Women.高蛋白质饮食联合或不联合益生元、益生菌和合生元对肠道微生物稳定性和胃肠道耐受性的影响:一项针对老年女性的随机、双盲、安慰剂对照试验
J Acad Nutr Diet. 2020 Apr;120(4):500-516.e10. doi: 10.1016/j.jand.2019.12.009.
5
Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adults.益生菌治疗成人功能性便秘的随机对照试验的荟萃分析。
Clin Nutr. 2020 Oct;39(10):2960-2969. doi: 10.1016/j.clnu.2020.01.005. Epub 2020 Jan 14.
6
Gut microbiota of obese subjects with Prader-Willi syndrome is linked to metabolic health.肥胖普拉德-威利综合征患者的肠道微生物群与代谢健康有关。
Gut. 2020 Jul;69(7):1229-1238. doi: 10.1136/gutjnl-2019-319322. Epub 2019 Oct 14.
7
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2.使用QIIME 2进行可重复、交互式、可扩展和可延伸的微生物组数据科学研究。
Nat Biotechnol. 2019 Aug;37(8):852-857. doi: 10.1038/s41587-019-0209-9.
8
Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update.普拉德-威利综合征——临床遗传学、诊断与治疗方法:最新进展
Curr Pediatr Rev. 2019;15(4):207-244. doi: 10.2174/1573396315666190716120925.
9
Daily Sampling Reveals Personalized Diet-Microbiome Associations in Humans.每日采样揭示人类饮食-微生物组的个性化关联。
Cell Host Microbe. 2019 Jun 12;25(6):789-802.e5. doi: 10.1016/j.chom.2019.05.005.
10
Emerging Health Concepts in the Probiotics Field: Streamlining the Definitions.益生菌领域的新兴健康概念:精简定义
Front Microbiol. 2019 May 21;10:1047. doi: 10.3389/fmicb.2019.01047. eCollection 2019.